LINDSAY MILLER: Open Payments
NPI 1235205931 · REDDING, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$724 in 24 payments from 9 companies in 2025. Trend: 2023 $3,835 · 2024 $6,314 · 2025 $724
Food & beverage: $655Education: $69
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $304 |
| Novartis Pharmaceuticals Corporation | 7 | $144 |
| ABBVIE INC. | 3 | $73 |
| Lilly USA, LLC | 3 | $55 |
| Galderma Laboratories, L.P. | 3 | $47 |
| LEO Pharma Inc. | 2 | $39 |
| Incyte Corporation | 1 | $26 |
| GENZYME CORPORATION | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
Products named: TREMFYA, COSENTYX, RINVOQ, TALTZ, NEMLUVIO, ADBRY, OPZELURA, DUPIXENT.
Industry payments across CA — which companies pay providers there.
